Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Infor Releases New Digital Innovation Enabler for Healthcare Industry

Posted on: 08 Jan 18
Infor Releases New Digital Innovation Enabler for Healthcare Industry Infor FHIR Bridge to enable Digital Innovation, Care Coordination, and Engagement with Existing Provider Systems

PR Newswire

NEW YORK, Jan. 8, 2018

NEW YORK, Jan. 8, 2018 /PRNewswire/ -- Infor, a leading provider of industry-specific cloud applications, today announced the availability of the Infor Fast Healthcare Interoperability Resources (FHIR) Bridge. Part of the Infor Cloverleaf Integration Suite, Infor FHIR Bridge delivers a cost-effective solution for healthcare organizations to realize better healthcare delivery, care coordination, and patient engagement through digital transformation made possible with FHIR®, the standards framework from HL7®.

Infor FHIR Bridge, built on the power and flexibility of the Cloverleaf® Integration Engine, enables healthcare organizations to utilize their current legacy systems and investment to interoperate with FHIR solutions and drive digital innovation. The solution bridges the gap that exists between traditional clinical systems that usually communicate in HL7 v2 or CDA®, and the emerging FHIR based application ecosystem, using a growing library of prebuilt standards adapters. Not only does Infor FHIR Bridge help bridge the gaps in systems' standards support, but it also can address the anomalies and variances between systems that inevitably occur, even when they are using the same standard.

"Infor FHIR Bridge is an intelligent solution allowing us to consolidate data from disparate applications securely and in real-time.  The biggest benefit is the reusability of the resources across multiple solutions resulting in timely development and deployment to our customers," said Mike Plesh, Director of Information Technology Integration Services, UNC Health Care.

Additionally, with Infor FHIR Bridge, providers will be able to greatly accelerate their ability to use FHIR the way that they choose rather than their EHR vendor's chosen apps or having to wait for costly and lengthy upgrades. It also greatly augments EHR systems' FHIR capabilities beyond the limited API support that they have today.

With Infor FHIR Bridge, healthcare organizations will be able to streamline care coordination by providing the information providers and patients need, and no more, thus eliminating receiving mass amounts of useless information through CDA documents.

"Infor understands that the need to share information across multiple platforms is paramount to achieving an interoperable infrastructure at health systems across the country," said Mark Weber, senior vice president, Healthcare, Infor. "We continue to innovate and invest in the Cloverleaf suite so our customers can continue to keep their focus on the patient, and ultimately provide safer, more effective care."

For more information please visit

About Infor
Infor builds business software for specific industries in the cloud. With 16,000 employees and over 90,000 customers in more than 170 countries, Infor software is designed for progress.  To learn more, please visit

HL7, FHIR and CDA are the registered trademarks of Health Level Seven International.

This announcement reflects the direction Infor may take with regard to the specific product(s) described herein, all of which is subject to change by Infor in its sole discretion, with or without notice to you.  This announcement is not a commitment to you in any way and you should not rely on this document or any of its content in making any decision.  Infor is not committing to develop or deliver any specified enhancement, upgrade, product or functionality, even if such is described in this announcement and even if such description is accompanied by words such as "anticipate," "believe," "expect," "intend," "may," "plan," "project," "predict," "should," "will," and/or similar expressions.  Many factors can affect Infor's product development plans and the nature, content and timing of future product releases, all of which remain in the sole discretion of Infor.  This announcement, in whole or in part, may not be incorporated into any contractual agreement with Infor or its subsidiaries or affiliates.  Infor expressly disclaims any liability with respect to this announcement.

For more information:
Christina Ledger                                             

View original content with multimedia:


PR Newswire

Last updated on: 08/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.